Infliximab (Remicade) adn etanercept (Enbrel): serious infections and tuberculosis.
Dunlop
Heather
H
Health Canada.
D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D002170:Canada / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D007239:Infections / Q000139:chemically induced* / Q000453:epidemiology; D000069285:Infliximab; D018124:Receptors, Tumor Necrosis Factor; D014376:Tuberculosis / Q000139:chemically induced* / Q000453:epidemiology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068800:Etanercept